Balmer Lawrie & Co Ltd was originally set up as a partnership firm by Stephen Balmer and Alexander Lawrie in 1867. It was taken over by IBP Co Ltd , a government company in the year 1972. The company has diversified business interests. It is the larg... More
Reliance Capital is one of the leading and fastest growing privates sector financial services companies in India. It is a part of the Reliance Anil Dhirubhai Ambani Group. The company offers wide gamut of services that includes asset management and m... More
BALMER LAWRIE | RELIANCE CAPITAL | BALMER LAWRIE/ RELIANCE CAPITAL |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 11.6 | -0.4 | - | View Chart |
P/BV | x | 1.4 | 0.0 | 7,784.7% | View Chart |
Dividend Yield | % | 8.3 | 102.5 | 8.1% |
![]() ![]() |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
BALMER LAWRIE Mar-19 |
RELIANCE CAPITAL Mar-18 |
BALMER LAWRIE/ RELIANCE CAPITAL |
5-Yr Chart Click to enlarge
|
||
High | Rs | 233 | 878 | 26.5% | |
Low | Rs | 160 | 394 | 40.6% | |
Sales per share (Unadj.) | Rs | 155.7 | 786.3 | 19.8% | |
Earnings per share (Unadj.) | Rs | 14.1 | 48.8 | 28.9% | |
Cash flow per share (Unadj.) | Rs | 16.8 | 54.5 | 30.8% | |
Dividends per share (Unadj.) | Rs | 10.00 | 11.00 | 90.9% | |
Dividend yield (eoy) | % | 5.1 | 1.7 | 294.3% | |
Book value per share (Unadj.) | Rs | 133.3 | 601.9 | 22.1% | |
Shares outstanding (eoy) | m | 114.00 | 252.63 | 45.1% | |
Bonus/Rights/Conversions | 169.00 | - | - | ||
Price / Sales ratio | x | 1.3 | 0.8 | 156.0% | |
Avg P/E ratio | x | 13.9 | 13.0 | 106.8% | |
P/CF ratio (eoy) | x | 11.7 | 11.7 | 100.3% | |
Price / Book Value ratio | x | 1.5 | 1.1 | 139.5% | |
Dividend payout | % | 70.8 | 22.5 | 314.2% | |
Avg Mkt Cap | Rs m | 22,401 | 160,698 | 13.9% | |
No. of employees | `000 | 1.1 | 18.2 | 5.9% | |
Total wages/salary | Rs m | 2,127 | 14,010 | 15.2% | |
Avg. sales/employee | Rs Th | 16,606.2 | 10,909.5 | 152.2% | |
Avg. wages/employee | Rs Th | 1,989.7 | 769.4 | 258.6% | |
Avg. net profit/employee | Rs Th | 1,507.0 | 677.7 | 222.4% |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 17,752 | 198,640 | 8.9% | |
Other income | Rs m | 578 | 340 | 170.0% | |
Total revenues | Rs m | 18,330 | 198,980 | 9.2% | |
Gross profit | Rs m | 2,262 | 58,070 | 3.9% | |
Depreciation | Rs m | 303 | 1,430 | 21.2% | |
Interest | Rs m | 71 | 40,260 | 0.2% | |
Profit before tax | Rs m | 2,466 | 16,720 | 14.7% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 855 | 4,380 | 19.5% | |
Profit after tax | Rs m | 1,611 | 12,340 | 13.1% | |
Gross profit margin | % | 12.7 | 29.2 | 43.6% | |
Effective tax rate | % | 34.7 | 26.2 | 132.3% | |
Net profit margin | % | 9.1 | 6.2 | 146.1% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 11,750 | 257,220 | 4.6% | |
Current liabilities | Rs m | 5,164 | 219,620 | 2.4% | |
Net working cap to sales | % | 37.1 | 18.9 | 196.0% | |
Current ratio | x | 2.3 | 1.2 | 194.3% | |
Inventory Days | Days | 29 | 0 | 53,311.3% | |
Debtors Days | Days | 57 | 20 | 287.3% | |
Net fixed assets | Rs m | 6,854 | 57,130 | 12.0% | |
Share capital | Rs m | 1,140 | 2,530 | 45.1% | |
"Free" reserves | Rs m | 14,055 | 149,540 | 9.4% | |
Net worth | Rs m | 15,195 | 152,070 | 10.0% | |
Long term debt | Rs m | 761 | 349,290 | 0.2% | |
Total assets | Rs m | 22,805 | 938,510 | 2.4% | |
Interest coverage | x | 35.6 | 1.4 | 2,517.5% | |
Debt to equity ratio | x | 0.1 | 2.3 | 2.2% | |
Sales to assets ratio | x | 0.8 | 0.2 | 367.8% | |
Return on assets | % | 7.4 | 5.6 | 131.6% | |
Return on equity | % | 10.6 | 8.1 | 130.7% | |
Return on capital | % | 15.9 | 11.4 | 139.9% | |
Exports to sales | % | 1.0 | 0 | - | |
Imports to sales | % | 1.8 | 0 | - | |
Exports (fob) | Rs m | 183 | NA | - | |
Imports (cif) | Rs m | 318 | NA | - | |
Fx inflow | Rs m | 751 | 0 | - | |
Fx outflow | Rs m | 1,390 | 80 | 1,736.9% | |
Net fx | Rs m | -638 | -80 | 797.8% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 1,941 | -50,650 | -3.8% | |
From Investments | Rs m | -1,369 | -7,760 | 17.6% | |
From Financial Activity | Rs m | -797 | 65,620 | -1.2% | |
Net Cashflow | Rs m | -226 | 7,210 | -3.1% |
Indian Promoters | % | 0.0 | 54.1 | - | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 11.2 | 7.7 | 145.5% | |
FIIs | % | 3.2 | 19.5 | 16.4% | |
ADR/GDR | % | 0.0 | 0.3 | - | |
Free float | % | 85.6 | 18.4 | 465.2% | |
Shareholders | 24,504 | 1,056,706 | 2.3% | ||
Pledged promoter(s) holding | % | 0.0 | 33.1 | - |
Compare BALMER LAWRIE With: EVEREADY INDUSTRIES E.I.D. PARRY CENTURY TEXTILES DELTA CORP 3M INDIA
Indian share markets witnessed a sharp sell-off during closing hours yesterday and ended lower.
For the quarter ended December 2019, BALMER LAWRIE has posted a net profit of Rs 358 m (up 33.2% YoY). Sales on the other hand came in at Rs 4 bn (down 5.6% YoY). Read on for a complete analysis of BALMER LAWRIE's quarterly results.
For the quarter ended June 2019, BALMER LAWRIE has posted a net profit of Rs 281 m (down 27.8% YoY). Sales on the other hand came in at Rs 4 bn (down 11.8% YoY). Read on for a complete analysis of BALMER LAWRIE's quarterly results.
For the quarter ended March 2019, BALMER LAWRIE has posted a net profit of Rs 883 m (up 0.4% YoY). Sales on the other hand came in at Rs 5 bn (down 0.7% YoY). Read on for a complete analysis of BALMER LAWRIE's quarterly results.
For the quarter ended December 2018, RELIANCE CAPITAL has posted a net profit of Rs 2 bn (down 34.9% YoY). Sales on the other hand came in at Rs 50 bn (up 5.3% YoY). Read on for a complete analysis of RELIANCE CAPITAL's quarterly results.
For the quarter ended December 2018, BALMER LAWRIE has posted a net profit of Rs 269 m (down 34.1% YoY). Sales on the other hand came in at Rs 4 bn (down 4.1% YoY). Read on for a complete analysis of BALMER LAWRIE's quarterly results.
More Views on NewsWere you shocked that bullion prices hit lower circuits on Friday on the MCX? Find out why it happened...
In this video, I'll show you why it might be the right time to take money of the table in pharma stocks.
Our ace stock picker is ready to capitalise on a big growth opportunity.
The pandemic failed to thwart Richa's investing success formula for 2020.
More